Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A.

@article{Threlfall2001DetectionOD,
  title={Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A.},
  author={Eric John Threlfall and Jeremy A. Skinner and Linda R. Ward},
  journal={The Journal of antimicrobial chemotherapy},
  year={2001},
  volume={48 5},
  pages={
          740-1
        }
}
Sir, Ciprofloxacin is now the first-line drug for the treatment of enteric fever and at the PHLS Laboratory of Enteric Pathogens (LEP) all strains of Salmonella enterica serotypes Typhi and Paratyphi A, B and C are tested for resistance to ciprofloxacin using an agar dilution breakpoint method. 1 The levels of ciprofloxacin incorporated into the media are 0.125 and 1 mg/L. Strains resistant at 0.125 mg/L but susceptible at 1 mg/L are regarded as exhibiting lowlevel resistance or decreased… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 33 CITATIONS

Pathogenicity of Salmonella Paratyphi A in Pullets

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Trends in antibiotic susceptibility of enteric fever isolates in East London.

  • Travel medicine and infectious disease
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

Similar Papers